UK MHRA Relies On Remote Drug GMP Inspections As COVID-19 Pandemic Grounds Inspectors

Experience from previous viral outbreaks has allowed the UK agency to move quickly; long-term focus is on hybrid inspection approach.

IT Engineer Wearing Virtual Reality Headset Works with Augmented Reality Software in Data Center. He Wirelessly Interacts with Rack Servers by Icon Visualisation.
uk inspectorate goes remote during covid-19 • Source: Shutterstock

The UK Medicines and Healthcare products Regulatory Agency is building upon experience from previous viral outbreaks as it rolls out an increasingly ambitious remote inspection program to help maintain the supply of existing medicines and approve new ones despite COVID-19 pandemic travel restrictions.

The MHRA’s program began quickly after the agency suspended routine site inspections on 20 March. Initial training began within a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance